Big Data
in 
Business Innovation
Rajendra Akerkar
Vestlandsforsking, Norway
R. Akerkar

2
Big data value
• Total 
coverage

Volume

R. Akerkar

Velocity
• Real‐time 
insights

• Self‐
reinforcing 

diversity

Var...
Big Data to Insight

R. Akerkar

4
Data can turn into 
valuable input
• Data-to-Information is the main source of big data value
for business models where in...
Open data

R. Akerkar

6
Data‐driven
management

R. Akerkar

7
DATA

Large volume of deep,
longitudinal data covering a 
diverse population.
Large public investments
in genomics, bioban...
Upcoming SlideShare
Loading in...5
×

Big data in Business Innovation

321

Published on

Published in: Education
0 Comments
2 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
321
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
2
Embeds 0
No embeds

No notes for slide

Big data in Business Innovation

  1. 1. Big Data in  Business Innovation Rajendra Akerkar Vestlandsforsking, Norway
  2. 2. R. Akerkar 2
  3. 3. Big data value • Total  coverage Volume R. Akerkar Velocity • Real‐time  insights • Self‐ reinforcing  diversity Variety 3
  4. 4. Big Data to Insight R. Akerkar 4
  5. 5. Data can turn into  valuable input • Data-to-Information is the main source of big data value for business models where information is the core source of value. o The data is “mined” for valuable information and the value is created the moment the search succeeds. • Data-to-Product/Process effect occurs when insights from data analysis need to be implemented in the physical world to bring value to an enterprise. • Data-to-Management steadily brings data based information into a company’s decision making process R. Akerkar 5
  6. 6. Open data R. Akerkar 6
  7. 7. Data‐driven management R. Akerkar 7
  8. 8. DATA Large volume of deep, longitudinal data covering a  diverse population. Large public investments in genomics, biobanks and integration of disease registries. INSIGHT Deep research Expertise. Specialised health data analytics  centres. VALUE R. Akerkar Large scale trials for diverse populations Models for commissioning Early stratification Pharmacovigilance 8

×